黑料官网

header-logo
GettyImages-609179959-hero
headshot

Anita D'Souza, MD

Professor of Medicine

view provider profile

Locations

  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Hindi

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Dr Anita D’Souza is a professor of medicine (hematology and oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, MN. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at 黑料官网.

Research Interests

Dr. D’Souza’s clinical and research work is focused on improving outcomes of individuals living with plasma cell disorders. She is actively involved in clinical trials focused on novel immunotherapies to treat these conditions. She has an NIH-funded independent research program focused on outcome research and survivorship. Current areas of research include:

I. Development of the AL-PROfile
Funding: CTSI/AHW Mentored Career Development Award (2016-2019), K23HL1414405 (2019-2023), PD/PI: D’Souza

Publications:

II. Early diagnosis of AL amyloidosis
Funding: R01HL16639 (2023-current), PD/PI: D’Souza

Publications:

III. Moving Forward with Multiple Myeloma
Funding: R01CA300310 (2025- current), MPI: Stolley/D’Souza/Sheehan

Publications:

Publications

  • (Estrada-Merly N, Pezzin LE, Sparapani R, D'Souza A.) JMIR Med Inform. 2026 Jun 22;14:e85803 PMID: 42330197 PMCID: PMC13286071 06/22/2026

  • (Vega G, Morillo D, Riedhammer C, Smits F, Bag A, Julian K, Gomis NT, Gaisan CM, Bermudez MA, Shah MR, Mohyuddin GR, Dhakal B, Rasche L, Schinke C, D'Souza A, Szabo A, van de Donk NWCJ, Chakraborty R, Mohan M.) Hemasphere. 2026 Jun;10(6):e70396 PMID: 42261378 PMCID: PMC13242627 06/09/2026

  • (Sperling AS, Derman BA, Nikiforow S, Alonso A, Ikegawa S, Orwitz N, Quinn DS, Pearson D, Bu D, Milanez-Almeida P, Mataraza J, Nadeem O, Liegel J, D'Souza A, Charles A, Credi M, Ritz J, Jakubowiak AJ, De Vita S, Munshi NC.) Sci Transl Med. 2026 May 27;18(851):eadx1799 PMID: 42202046 PMCID: PMC13427373 05/27/2026

  • (Wood WA, Kumar SK, Semmel EA, James S, Schroeder MA, Chung DJ, Rosenberg A, Zonder J, Rubinstein S, D'Souza A, Martin T, Chari A, Vij R, Nooka AK, Anderson KC, Neuberg DS, Richard S, Torres K, Weiss BM, Pederson L, Derkach A, Geyer S, Usmani SZ.) Blood Adv. 2026 May 12;10(9):3094-3102 PMID: 41734388 PMCID: PMC13141511 02/24/2026

  • (Aughey E, Estrada-Merly N, Akhtar OS, Dhakal B, Mohan M, Narra R, Pasquini MC, D'Souza A.) Br J Haematol. 2026 May;208(5):1836-1840 PMID: 41797476 SCOPUS ID: 2-s2.0-105032145910 03/09/2026

  • (Mellgard GS, Bazarbachi AH, Zanwar S, Hegenbart U, Bodanapu G, Bhutani D, Chen G, D'Souza A, Dispenzieri A, Gertz M, Kumar S, Lentzsch S, Milani P, Muchtar E, Palladini G, Trajanova D, Patwari A, Sanchorawala V, Mohty M, Wang S, Kastritis E, Theodorakakou F, Schönland S, Chakraborty R, Cowan AJ.) Am J Hematol. 2026 Apr;101(4):768-783 PMID: 41793153 03/07/2026

  • (Shah UA, Cogrossi LL, Garcés JJ, Policastro A, Castro F, Derkach A, Fei T, DeWolf S, Grioni M, Sisti S, Blaslov J, Adintori PA, Hosszu KK, McAvoy D, Baichoo M, Cross JR, Paredes J, Anuraj A, Raj SS, Pohl C, Zordan P, Zinsmeyer V, Jesus Faustino Ramos RJ, Lorenzoni M, Gipson B, Maclachlan KH, Gradissimo A, Boiocchi L, Aleynick N, Marchigiani C, Pagani S, Salehi E, Koche RP, Chaligne R, Block T, Korde N, Tan CR, Hultcrantz M, Hassoun H, Shah GL, Scordo M, Lahoud OB, Chung DJ, Landau HJ, Peled JU, Clementi N, Chesi M, Bergsagel PL, Mailankody S, Pollak MN, D'Souza A, Landgren O, Chimonas S, Giralt SA, Usmani SZ, Iyengar NM, Lesokhin AM, van den Brink MRM, Bellone M.) Cancer Discov. 2026 Apr 01;16(4):697-720 PMID: 41342739 PMCID: PMC12811828 12/04/2025

  • (Mohan M, Danziger N, Akhtar OS, Narra R, Pasquini MC, Radhakrishnan S, Dhakal B, D'Souza A, Lin D, Ho C, Kurzrock R.) Blood Adv. 2026 Feb 24;10(4):1400-1404 PMID: 41411484 PMCID: PMC12927052 SCOPUS ID: 2-s2.0-105030120191 12/18/2025

  • (Arsang-Jang S, Massat B, Pareek G, Han J, Thapa B, Patek V, Nader Z, Auer PL, Zimmerman MT, Urrutia R, Hari P, D'Souza A, Dhakal B, Janz S, Dong J.) HLA. 2026 Feb;107(2):e70589 PMID: 41685425 PMCID: PMC12902906 SCOPUS ID: 2-s2.0-105029925738 02/13/2026

  • (Wu JF, Estrada-Merly N, Zhou Y, Canales B, Yen TWF, D'Souza A.) Bone Marrow Transplant. 2026 Jan;61(1):95-97 PMID: 41083569 PMCID: PMC12590446 SCOPUS ID: 2-s2.0-105018757703 10/14/2025

  • (Bazarbachi AH, Zanwar S, Hegenbart U, Trajanova D, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Mohty M, Lentzsch S, Schönland SO, Muchtar E, Chakraborty R.) Hemasphere. 2025 Dec;9(12):e70276 PMID: 41473002 PMCID: PMC12745042 12/31/2025

  • (Al Hadidi S, Szabo A, Mohan Lal B, Bag A, Zhen S, Ogunsesan Y, Annyapu E, Dhakal B, Bhutani D, Thanendrarajan S, Zangari M, D'Souza A, Lentzsch S, van Rhee F, Chakraborty R, Schinke C, Mohan M, Shah MR.) Blood Cancer J. 2025 Nov 07;15(1):196 PMID: 41203605 PMCID: PMC12594773 SCOPUS ID: 2-s2.0-105021068508 11/08/2025

Publications of Anita D'Souza MD from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.